A recent prospective cross-sectional study in Thailand demonstrates that multitarget stool DNA testing is highly sensitive and specific for detecting colorectal cancer (CRC) among Thai individuals.

Exact Sciences (NASDAQ:EXAS) has received approval from the U.S. Food and Drug Administration (FDA) for its non-invasive multitarget stool DNA test to detect colorectal cancer in adults ages 45 and ...

CRANSTON, R.I. (WPRI) — The Cranston Fire Department has become the first in Rhode Island to test new cancer-screening technology. EsoGuard is a non-invasive DNA test, introduced by Lucid Diagnostics, ...

When 70-year-old Hanka Kowalski from Pruszków, a small city in Central Poland, received the results from a simple and non-invasive DNA test, she was stunned—it came back positive for early-stage ...